View in EDS HTML Full Text PDF Full Text

Anti-IL-5 and anti-IL-5 receptor therapy significantly improves quality of life and FEV1 values in patients with severe asthma.

Saved in:
Bibliographic Details
Title: Anti-IL-5 and anti-IL-5 receptor therapy significantly improves quality of life and FEV1 values in patients with severe asthma.
Authors: Alfaro, Anaiza Odalis Villalobos1 (AUTHOR), Vargas, Haydee Carolina Gutiérrez2 (AUTHOR), Díaz, Juan Manuel3 (AUTHOR), Pinto, Jonathan Alvarez4 (AUTHOR), Cambero, Diana Cristina García5 (AUTHOR), Cuellar, Eduardo Hernandez6 (AUTHOR), Zapata, Julio Augusto Palma7 (AUTHOR), Domínguez, Alondra Esthefanía Llamas7 (AUTHOR), Zapata, Juliana Palma7 (AUTHOR), Ponce-Campos, Silvia Denise2 (AUTHOR) denise_ponce@hotmail.com
Source: Allergy, Asthma & Clinical Immunology. 8/13/2025, Vol. 21 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17101484
DOI:10.1186/s13223-025-00979-y